The fifth Iranian-made COVID-19 vaccine has been permitted to undergo the Phase II of its clinical trial.
The recombinant vaccine has been produced by Cinnagen company, and is the first one developed by the private sector.
Four other homegrown vaccines are already undergoing their clinical trials at different phases.
The Covo-Pars vaccine developed by Razi Institute, the conjugate vaccine jointly developed by Iran’s Pasteur Institute and Cuba’s Finlay Institute, the CovIran Barekat vaccine funded by the Executive Office of Imam Khomeini’s Order, and the Fakhra vaccine funded by the Iranian Ministry of Defence are the other four vaccines that are passing their final tests.
Iran’s former president Hassan Rouhani has criticized "hardliners of the country for their pressures" on…
The Iranian NGO, Center for Peace and Environment, has announced UN Special Rapporteur on human…
The CEO of Iran’s Tavanir Company has announced that Iraq will continue importing electricity from…
A trilateral meeting between Iran, China, and Russia was held in Beijing on Friday to…
The Iranian Ministry of Petroleum announced that the inclusion of Mohsen Paknejad, Iran's Minister of…
Iranian Foreign Ministry has summoned the ambassadors of the UK, France and Germany in protest…
